Mexiletine suppresses nodal persistent sodium currents in sensory axons of patients with neuropathic pain
- PMID: 20097124
- DOI: 10.1016/j.clinph.2009.12.034
Mexiletine suppresses nodal persistent sodium currents in sensory axons of patients with neuropathic pain
Abstract
Objective: To investigate changes in axonal persistent Na(+) currents in patients with neuropathic pain and the effects of mexiletine, an analogue of lidocaine, on axonal excitability properties.
Methods: The technique of latent addition was used to estimate nodal persistent Na(+) currents in superficial radial sensory axons of 17 patients with neuropathic pain/paresthesias before and after mexiletine treatment. Brief hyperpolarizing conditioning currents were delivered, and threshold change at the conditioning-test interval of 0.2 ms was measured as an indicator of the magnitude of persistent Na(+) currents.
Results: Threshold changes at 0.2 ms in latent addition were greater in the neuropathic patients than in the normal controls (p<0.001). After mexiletine treatment, there was a reduction in clinical pain scores (p<0.001), associated with decreased threshold changes at 0.2 ms (p<0.001).
Conclusions: In patients with neuropathy, nodal persistent Na(+) currents in large sensory fibers increase, and the abnormal currents can be suppressed by mexiletine. Pain reduction after mexiletine treatment raises the possibility that excessive Na(+) currents are also suppressed in small fibers mediating neuropathic pain.
Significance: Latent addition can be used for indirect in vivo monitoring of nodal Na(+) currents in large sensory fibers, and future studies using this approach in small fibers would provide new insights into the peripheral mechanism of neuropathic pain.
Copyright 2010 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
The effects of mexiletine on excitability properties of human median motor axons.Clin Neurophysiol. 2005 Feb;116(2):284-9. doi: 10.1016/j.clinph.2004.08.014. Clin Neurophysiol. 2005. PMID: 15661106 Clinical Trial.
-
Increased nodal persistent Na+ currents in human neuropathy and motor neuron disease estimated by latent addition.Clin Neurophysiol. 2006 Nov;117(11):2451-8. doi: 10.1016/j.clinph.2006.07.309. Epub 2006 Sep 25. Clin Neurophysiol. 2006. PMID: 16996798
-
Latent addition in human motor and sensory axons: different site-dependent changes across the carpal tunnel related to persistent Na+ currents.Clin Neurophysiol. 2006 Apr;117(4):810-4. doi: 10.1016/j.clinph.2005.11.018. Epub 2006 Feb 21. Clin Neurophysiol. 2006. PMID: 16497550
-
Therapeutic concentrations of local anaesthetics unveil the potential role of sodium channels in neuropathic pain.Novartis Found Symp. 2002;241:189-201; discussion 202-5, 226-32. Novartis Found Symp. 2002. PMID: 11771646 Review.
-
Pharmacologic intervention in axonal excitability: in vivo assessment of nodal persistent sodium currents in human neuropathies.Curr Mol Pharmacol. 2008 Jan;1(1):61-7. doi: 10.2174/1874467210801010061. Curr Mol Pharmacol. 2008. PMID: 20021424 Review.
Cited by
-
Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.Ann Neurol. 2022 Apr;91(4):506-520. doi: 10.1002/ana.26319. Epub 2022 Mar 7. Ann Neurol. 2022. PMID: 35150149 Free PMC article.
-
Challenges and opportunities in translational pain research - An opinion paper of the working group on translational pain research of the European pain federation (EFIC).Eur J Pain. 2021 Apr;25(4):731-756. doi: 10.1002/ejp.1730. Epub 2021 Feb 24. Eur J Pain. 2021. PMID: 33625769 Free PMC article.
-
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).Trials. 2022 Feb 19;23(1):163. doi: 10.1186/s13063-022-06087-1. Trials. 2022. PMID: 35183242 Free PMC article.
-
Neuronal hyperexcitability: a substrate for central neuropathic pain after spinal cord injury.Curr Pain Headache Rep. 2011 Jun;15(3):215-22. doi: 10.1007/s11916-011-0186-2. Curr Pain Headache Rep. 2011. PMID: 21387163 Review.
-
Membrane Stabilizer Medications in the Treatment of Chronic Neuropathic Pain: a Comprehensive Review.Curr Pain Headache Rep. 2019 May 1;23(6):37. doi: 10.1007/s11916-019-0774-0. Curr Pain Headache Rep. 2019. PMID: 31044330 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources